106 related articles for article (PubMed ID: 3082553)
1. Monitoring of ovarian response to stimulation in in-vitro fertilization cycles.
Kerin JF; Warnes GM
Clin Obstet Gynecol; 1986 Mar; 29(1):158-70. PubMed ID: 3082553
[No Abstract] [Full Text] [Related]
2. Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET).
Kemeter P; Feichtinger W
Experientia; 1985 Dec; 41(12):1502-7. PubMed ID: 3935476
[No Abstract] [Full Text] [Related]
3. Ovarian hyperstimulation for successful in vitro fertilization and embryo transfer.
Gronow MJ
Acta Obstet Gynecol Scand Suppl; 1985; 131():1-80. PubMed ID: 3925706
[No Abstract] [Full Text] [Related]
4. Patterns of estradiol response in patients with endogenous gonadotropin surges during follicular recruitment in an in vitro fertilization and embryo transfer program.
Nader S; Berkowitz AS; Ochs D; Wolf DP; Maklad N; Held B
Fertil Steril; 1986 Sep; 46(3):448-51. PubMed ID: 3091410
[TBL] [Abstract][Full Text] [Related]
5. Ovarian stimulation regimens in an in vitro fertilization program: a comparative analysis.
Bayly CM; McBain JC; Clarke GA; Gronow MJ; Johnston WI; Martin MJ; Speirs AL
Ann N Y Acad Sci; 1985; 442():123-7. PubMed ID: 3925832
[No Abstract] [Full Text] [Related]
6. Ovarian function for multiple follicle maturation.
Hodgen GD
Clin Obstet Gynecol; 1986 Mar; 29(1):127-40. PubMed ID: 3082550
[No Abstract] [Full Text] [Related]
7. [Special aspects of ovarian stimulation and in vitro fertilization].
Lejeune B; Camus M; Vekemans M; Deschacht J; d'Oultremont G; Leroy F
Rev Med Brux; 1985 Nov; 6(9):605-9. PubMed ID: 3936148
[No Abstract] [Full Text] [Related]
8. Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation.
Bagratee JS; Lockwood G; López Bernal A; Barlow DH; Ledger WL
J Assist Reprod Genet; 1998 Feb; 15(2):65-9. PubMed ID: 9513843
[TBL] [Abstract][Full Text] [Related]
9. Relationships between the characteristics of endogenous luteinizing hormone surge and the degree of ovarian hyperstimulation during superovulation induction in women.
Messinis IE; Templeton A; Baird DT
Clin Endocrinol (Oxf); 1986 Oct; 25(4):393-400. PubMed ID: 3113775
[TBL] [Abstract][Full Text] [Related]
10. Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins.
Wildt L; Diedrich K; van der Ven H; al Hasani S; Hübner H; Klasen R
Hum Reprod; 1986 Jan; 1(1):15-9. PubMed ID: 2971082
[TBL] [Abstract][Full Text] [Related]
11. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
Usui A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
[TBL] [Abstract][Full Text] [Related]
12. Withholding gonadotropins ("coasting") to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles.
Fluker MR; Hooper WM; Yuzpe AA
Fertil Steril; 1999 Feb; 71(2):294-301. PubMed ID: 9988401
[TBL] [Abstract][Full Text] [Related]
13. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
Gersak K; Meden-Vrtovec H; Tomazevic T
Hum Reprod; 1994 Sep; 9(9):1596-9. PubMed ID: 7836506
[TBL] [Abstract][Full Text] [Related]
14. Concepts in human in vitro fertilization and embryo transfer.
Lopata A
Fertil Steril; 1983 Sep; 40(3):289-301. PubMed ID: 6350050
[No Abstract] [Full Text] [Related]
15. Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin.
Golan A; Herman A; Soffer Y; Bukovsky I; Ron-El R
Hum Reprod; 1994 Sep; 9(9):1631-3. PubMed ID: 7836512
[TBL] [Abstract][Full Text] [Related]
16. Preliminary data on the efficacy of a new human menopausal gonadotropin (hMG) preparation containing a reduced amount of luteinizing hormone (LH) for superovulation in an in vitro fertilization (IVF) program.
Antoine JM; Salat-Baroux J; Alvarez S; Cornet D; Tibi C; Brieu V; Mandelbaum J; Plachot M
J Assist Reprod Genet; 1992 Aug; 9(4):404-6. PubMed ID: 1472821
[No Abstract] [Full Text] [Related]
17. Relationship between the threshold of ovarian sensitivity to human menopausal gonadotrophin stimulation and in-vitro fertilization treatment outcome.
Shulman A; Ghetler Y; Fejgin M; Kaneti H; Weinstein S; Beyth Y; Ben-Nun I
Hum Reprod; 1995 Dec; 10(12):3198-201. PubMed ID: 8822443
[TBL] [Abstract][Full Text] [Related]
18. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.
Lindheim SR; Cohen MA; Chang PL; Sauer MV
J Assist Reprod Genet; 1999 May; 16(5):242-6. PubMed ID: 10335470
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of serum inhibin B measurement for evaluation of ovarian reserve in controlled ovarian hyperstimulation].
Wu RR; Liao YC; Ye Y; Du Y; Ke WN; Zhang XB; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):679-81. PubMed ID: 16277899
[TBL] [Abstract][Full Text] [Related]
20. Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins.
Awadalla SG; Friedman CI; Chin NW; Dodds W; Park JM; Kim MH
Fertil Steril; 1987 Nov; 48(5):811-5. PubMed ID: 3117593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
